StonvexLoading…
StonvexStonvexStonvexCore line items from AVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $278.60M | $1.39B | $1.07B | $714.50M |
Operating Income | $2.50M | $65.20M | $37.20M | $16.20M |
Net Income | $-700.00K | $37.70M | $21.70M | $7.00M |
EPS (Diluted) | $-0.01 | $0.53 | $0.30 | $0.10 |
Total Assets | $997.70M | $983.00M | $1.00B | $1.01B |
Total Liabilities | $377.60M | $363.10M | $401.90M | $426.20M |
Cash & Equivalents | $44.80M | $64.80M | $43.70M | $36.70M |
Free Cash Flow OCF − CapEx | $-14.90M | $37.20M | $-18.40M | $-41.00M |
Shares Outstanding | 70.84M | 70.57M | 70.62M | 70.62M |